Hamps Bio Limited specialises in pharmaceutical formulations and freeze-drying ingredients. On July 29, 2025, their board will discuss increasing the authorised share capital and amending the Memorandum of Association. They'll also consider a bonus share issue to existing shareholders, distributing additional shares at no cost. The stock is currently up over 50% from its 52-week low of ₹34.21.